ym 872 has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, M; Ishiuchi, S; Ohtani, T; Watanabe, T | 1 |
| Hagimura, N; Ishiuchi, S; Kurihara, H; Miwa, A; Nakazato, Y; Okado, H; Ozawa, S; Sasaki, T; Tamura, M; Tsuzuki, K; Yamada, N; Yoshida, Y | 1 |
2 other study(ies) available for ym 872 and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Glioblastoma; Humans; Imidazoles; In Vitro Techniques; Mice; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Quinoxalines; Receptors, AMPA; Receptors, Platelet-Derived Growth Factor; Transplantation, Heterologous; Treatment Outcome; Tyrphostins | 2013 |
Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.
Topics: Adenoviridae; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Apoptosis; Brain Neoplasms; Calcium; Cell Movement; Genetic Vectors; Glioblastoma; Humans; Imidazoles; Mice; Mice, Nude; Permeability; Quinoxalines; Receptors, AMPA; Tumor Cells, Cultured | 2002 |